U.S. FDA Approves Biogen’s SPINRAZA

U.S. FDA Approves Biogen’s SPINRAZA™ (nusinersen), The First Treatment for Spinal Muscular Atrophy.SPINRAZA is the first and only treatment approved in the U.S. for SMA, a leading genetic cause of death in infants and toddlers that is marked by progressive, debilitating muscle weakness.

Source:
www.businesswire.com/news/home/20161223005361/en/U.S.-FDA-Approves-Biogen%E2%80%99s-SPINRAZA%E2%84%A2-nusinersen-Treatment